actr3
-
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patients, 2026, Heumann et al
Abstract: Fatigue is a common symptom of cancer patients, which can impair quality of life even years after treatment. Little is known about genetic determinants of fatigue, especially in prostate cancer (PCa). This study aims to identify SNPs associated with long-term fatigue in a prospective...- Nightsong
- Thread
- actr3 cbwd2 fatigue genetics prostate cancer
- Replies: 1
- Forum: Other health news and research